Limbic Striatal Dopamine D2/3 Receptor Availability is Associated with Non-planning Impulsivity in Healthy Adults After Exclusion of Potential Dissimulators
Overview
Authors
Affiliations
Positron emission tomography (PET) studies have reported an association between reduced striatal dopamine D2/3 receptor availability and higher scores on self-report measures of trait impulsivity in healthy adults. However, impulsivity is a multi-faceted construct, and it is unclear which aspect(s) of impulsivity might be driving these associations. The current study aimed to investigate the relationship between limbic (ventral) striatal D2/3 receptor availability and individual components of impulsivity (attentional, motor and non-planning) using the Barratt Impulsiveness Scale (BIS-11) and [(11)C]raclopride PET in 23 healthy volunteers. A partial correlational analysis showed a significant association between non-planning impulsiveness (lack of forethought or 'futuring') and limbic D2/3 receptor availability, which was only apparent after the exclusion of potential dissimulators (indexed by high scores on impression management). Our findings suggest that non-planning impulsiveness is associated with individual variation in limbic striatal D2/3 receptor availability and that different facets of impulsivity may have specific neurochemical correlates. Future studies that combine D2/3 receptor imaging with behavioral measures of impulsivity are required to further elucidate the precise relationship between individual components of trait impulsivity and brain dopaminergic function.
Trait Impulsivity as a Feature of Parkinson's Disease Treatment and Progression.
Spencer H, Anderton R Parkinsons Dis. 2024; 2024:8770997.
PMID: 38766569 PMC: 11102119. DOI: 10.1155/2024/8770997.
Accentuated Paralimbic and Reduced Mesolimbic D-Impulsivity Associations in Parkinson's Disease.
Stark A, Song A, Petersen K, Hay K, Lin Y, Trujillo P J Neurosci. 2023; 43(50):8733-8743.
PMID: 37852792 PMC: 10727183. DOI: 10.1523/JNEUROSCI.1037-23.2023.
Uruena-Mendez G, Dimiziani A, Belles L, Goutaudier R, Ginovart N Int J Mol Sci. 2023; 24(17).
PMID: 37686044 PMC: 10487888. DOI: 10.3390/ijms241713238.
Bakeberg M, Riley M, Byrnes M, Jefferson A, Ghosh S, Horne M Parkinsons Dis. 2020; 2020:8296203.
PMID: 33062249 PMC: 7545407. DOI: 10.1155/2020/8296203.
Strickland J, Johnson M Psychol Rev. 2020; 128(2):336-361.
PMID: 32969672 PMC: 8610097. DOI: 10.1037/rev0000263.